van 't Veer C, Golden N J, Kalafatis M, Mann K G
Department of Biochemistry, University of Vermont, Burlington, Vermont 05405-0068, USA.
J Biol Chem. 1997 Mar 21;272(12):7983-94. doi: 10.1074/jbc.272.12.7983.
The effects of the components of the protein C pathway on thrombin generation were studied in a reconstituted model in which thrombin is generated by factor VIIa and relipidated tissue factor (TF) via the activation of the purified coagulation factors X, IX, VIII, V, and prothrombin. The influence of protein C and soluble thrombomodulin on thrombin generation was correlated with factor Xa generation, factor V(a) and factor VIII(a) formation/inactivation, and protein C activation. Thrombin generation initiated by low concentrations of factor VIIa.TF (1.25 pM) occurs in an explosive fashion during a propagation phase which occurs after an initiation phase of approximately 1 min in which only traces of thrombin are formed. In the absence of other inhibitors, protein C (65 nM) in combination with high concentrations of soluble thrombomodulin (10 nM) resulted in a reduced rate of thrombin generation during the propagation phase without affecting the initiation phase; the activated protein C generated failed to neutralize prothrombinase activity and did not prevent prothrombin consumption. In the presence of plasma levels of the tissue factor pathway inhibitor (2. 5 nM recombinant TFPI), the protein C pathway reduced the rate of thrombin generation, initiated by 1.25 pM factor VIIa.TF, and completely eliminated prothrombinase activity at soluble thrombomodulin concentrations of >/=1 nM. The neutralization of prothrombinase activity coincided with cleavages at Arg-506 and subsequent cleavage at Arg-306 of the factor Va heavy chain by activated protein C. Thus, the protein C pathway combined with TFPI creates a minimal inhibitory potential required to shut down TF-initiated thrombin generation. The protein C pathway constituents did not influence factor Xa generation or factor VIIIa degradation over the interval in which prothrombinase activity was neutralized. Our data thus suggest that the protein C pathway regulates thrombin generation solely by the inactivation of factor Va. At low initiating factor VIIa.TF (1.25 pM) and high thrombomodulin concentrations (10 nM), the factor Va heavy chain is cleaved before significant amounts of light chain are generated. The ability of the protein C pathway to inhibit thrombin generation was greatly reduced when the reaction was initiated in the presence of factor Va, supporting the hypothesis that effective down-regulation of thrombin generation by the protein C pathway, in reactions initiated with the procofactor, occurs by prevention of the coexistence of the factor Va heavy and light chains.
在一个重组模型中研究了蛋白C途径的组分对凝血酶生成的影响,在该模型中,凝血酶由因子VIIa和重新脂质化的组织因子(TF)通过激活纯化的凝血因子X、IX、VIII、V和凝血酶原生成。蛋白C和可溶性血栓调节蛋白对凝血酶生成的影响与因子Xa生成、因子V(a)和因子VIII(a)的形成/失活以及蛋白C激活相关。低浓度因子VIIa.TF(1.25 pM)引发的凝血酶生成在一个约1分钟的起始阶段后出现的传播阶段以爆发方式发生,在起始阶段仅形成微量凝血酶。在没有其他抑制剂的情况下,蛋白C(65 nM)与高浓度可溶性血栓调节蛋白(10 nM)联合导致传播阶段凝血酶生成速率降低,而不影响起始阶段;生成的活化蛋白C未能中和凝血酶原酶活性,也未阻止凝血酶原消耗。在存在血浆水平的组织因子途径抑制剂(2.5 nM重组TFPI)的情况下,蛋白C途径降低了由1.25 pM因子VIIa.TF引发的凝血酶生成速率,并在可溶性血栓调节蛋白浓度≥1 nM时完全消除了凝血酶原酶活性。凝血酶原酶活性的中和与活化蛋白C对因子Va重链在Arg-506处的切割以及随后在Arg-306处的切割同时发生。因此,蛋白C途径与TFPI结合产生了关闭TF引发的凝血酶生成所需的最小抑制潜能。在凝血酶原酶活性被中和的时间段内,蛋白C途径的组分不影响因子Xa生成或因子VIIIa降解。我们的数据因此表明,蛋白C途径仅通过因子Va的失活来调节凝血酶生成。在低起始因子VIIa.TF(1.25 pM)和高血栓调节蛋白浓度(10 nM)时,因子Va重链在大量轻链生成之前就被切割。当反应在因子Va存在下起始时,蛋白C途径抑制凝血酶生成的能力大大降低,支持了这样的假设,即在由辅因子起始的反应中,蛋白C途径对凝血酶生成的有效下调是通过防止因子Va重链和轻链共存来实现的。